Aristotle University Of Thessaloniki (AUTH)
Μελέτη των μεταβολών της αιμόστασης στην ενδαγγειακή χειρουργική
Abstract
dc:descriptionIntroduction: The aim of the study is the monitoring of haemostatic changes of patients with arterial obstructive disease undergoing endovascular treatment. We studied the ability of Minimal Tissue Factor triggered (MinTF-TEM) whole blood thrombelastography to assess the antithrombotic effect of therapeutic regimen of Low Molecular Weight Heparins (LMWHs) administered in patients undergoing carotid angioplasty and stenting (CAS). Patients – Method: With the use of a ROTEM® device (Rotational thromboelastometry), standard thromboelastography assays (in-TEM®, ex-TEM) and MinTF-TEM assay in citrated whole blood were performed in normal volunteers (n=20), in patients with carotid artery disease receiving only antiplatelet treatment (n=30), and in patients undergoing CAS receiving nadroparin 5750 anti-Xa IU s.c. twice daily (n=60). Blood samples were collected 4 hours after the 3rd injection of LMWH. In a subgroup of LMWH patients (n=18) blood samples were also obtained prior to 1st injection of LMWH. Anti-factor-Xa activity in platelet-poor plasma (PPP) was also measured in those 18 patients. Results: Antiplatelet treatment had no effect on any parameter of the thromboelastographic pattern. LMWH (nadroparin) treatment resulted in significant prolongation of clotting time (CT) and clot formation time (CFT) and significantly reduced α-angle in minimal TF-triggered thromboelastography. Of the nadroparin treated patients 30-38% had thromboelastographic parameters beyond the normal maximum limit (NMaxL). In-TEM® test revealed a significant prolongation of clotting time while ex-TEM® was not modified, and 20to 30% of the patients had thromboelastographic parameters beyond the normal maximum limit. Statistical analysis of anti-factor-Xa activity measurement, showed that prolongation of CFT of MinTF-TEM was significantly correlated to the levels of anti-Xa activity in patients’ plasma (p=0.04; r 2 =0.7). There was no statistical correlation for any other parameter in all tests. Conclusion: Patients of high atherothrombotic risk such as those suffering from carotid artery obstructive disease being under double antiplatelet drugs’ treatment, have normal thrombus formation kinetics and normal thrombus stability. LMWH (nadroparin) treatment induces significant of the thrombus kinetics assessed by Minimal TF triggered whole blood thrombelastography. The assay can be implemented in- or by the side of the operating room without any loss of laboratory accuracy.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Konstantinidis, Konstantinos
- Κωνσταντινίδης, Κωνσταντίνος
Subjects
dc:subject × 18- Καταγραφή μεταβολών αιμόστασης
- Ενδαγγειακή αγγειοχειρουργική
- Αγγειοπλαστική καρωτίδων
- Αντιπηκτική θεραπεία
- Ηπαρίνες μικρού μοριακού βάρους
- Αντιαιμοπεταλιακή θεραπεία
- Θρομβοελαστογραφία
- Monitoring of haemostasis
- Endovascular surgery
- Carotid angioplasty
- Anticoangulant therapy
- Low molecular weight heparin (LMWH)
- Antiplatelet therapy
- Thromboelastography
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19494